Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2017 Filed Jun 17, 2017 00:05 UTC |
RIKER LAURENVice President, Finance
|
GrantStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040681 · doc4.xml · derivative · entry 2 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:05 UTC |
RIKER LAURENVice President, Finance
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040681 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,063 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:02 UTC |
Jones James BSVP & Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040678 · doc4.xml · derivative · entry 2 Jones James B · CIK 0001650857 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:02 UTC |
Jones James BSVP & Chief Medical Officer
|
GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040678 · doc4.xml · nonDerivative · entry 1 Jones James B · CIK 0001650857 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,313 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 23:08 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 1,119 | $44.37 | $49,650.03 |
DisclosureSEC source: 0001209191-17-039011 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,063 Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 22:57 UTC |
Braunstein ScottSVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 768 | $43.32 | $33,270.53 |
DisclosureSEC source: 0001209191-17-038416 · doc4.xml · nonDerivative · entry 1 Braunstein Scott · CIK 0001643875 · SVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,982 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 23:03 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
SaleCommon Stock | 1,877 | $43.32 | $81,313.52 |
DisclosureSEC source: 0001209191-17-038425 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,773 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 19:02 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 4,311 | $43.32 | $186,756.83 |
DisclosureSEC source: 0001209191-17-038423 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,559 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 19:00 UTC |
Scibetta James SPresident
|
SaleCommon Stock | 1,966 | $43.32 | $85,169.09 |
DisclosureSEC source: 0001209191-17-038420 · doc4.xml · nonDerivative · entry 1 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,118 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 22:58 UTC |
Jones James BSVP & Chief Medical Officer
|
SaleCommon Stock | 767 | $43.32 | $33,227.21 |
DisclosureSEC source: 0001209191-17-038417 · doc4.xml · nonDerivative · entry 1 Jones James B · CIK 0001650857 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,813 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 330 shares of common stock acquired under the issuer's employee stock purchase plan in June 2016. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 22:59 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 601 | $43.32 | $26,035.92 |
DisclosureSEC source: 0001209191-17-038418 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,182 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 330 shares of common stock acquired under the issuer's employee stock purchase plan in June 2016. Read SEC document |
| June 02, 2017 Filed Jun 17, 2017 00:01 UTC |
Braunstein ScottSVP, Strategy & Corp. Dev.
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $44.10 | $0.00 |
DisclosureSEC source: 0001209191-17-040677 · doc4.xml · derivative · entry 2 Braunstein Scott · CIK 0001643875 · SVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-02 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on May 29, 2018, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:45 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,979 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-17-033405 · doc4.xml · derivative · entry 7 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,979 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and as to the remaining option shares in successive equal monthly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:45 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,937 | $0.00 Strike: $10.52 | $0.00 |
DisclosureSEC source: 0001209191-17-033405 · doc4.xml · derivative · entry 6 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,937 shares Expires 2022-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and as to the remaining option shares in successive equal monthly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:45 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,125 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001209191-17-033405 · doc4.xml · derivative · entry 5 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,125 shares Expires 2021-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and as to the remaining option shares in successive equal monthly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:45 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
SaleCommon Stock | 21,041 | $50.86 | $1,070,145.26 |
DisclosureSEC source: 0001209191-17-033405 · doc4.xml · nonDerivative · entry 4 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,650 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.75 to $51.00, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:45 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionCommon Stock | 11,979 | $10.81 | $129,492.99 |
DisclosureSEC source: 0001209191-17-033405 · doc4.xml · nonDerivative · entry 3 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:45 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionCommon Stock | 5,937 | $10.52 | $62,457.24 |
DisclosureSEC source: 0001209191-17-033405 · doc4.xml · nonDerivative · entry 2 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:45 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionCommon Stock | 3,125 | $9.25 | $28,906.25 |
DisclosureSEC source: 0001209191-17-033405 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2017 Filed May 17, 2017 18:44 UTC |
Scibetta James SPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001209191-17-033404 · doc4.xml · derivative · entry 3 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,251 Underlying: Common Stock · 20,000 shares Expires 2020-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering. Read SEC document |
| May 15, 2017 Filed May 17, 2017 18:44 UTC |
Scibetta James SPresident
|
SaleCommon Stock | 20,000 | $51.20 | $1,024,000.00 |
DisclosureSEC source: 0001209191-17-033404 · doc4.xml · nonDerivative · entry 2 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,084 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.60, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2017 Filed May 17, 2017 18:44 UTC |
Scibetta James SPresident
|
Exercise / conversionCommon Stock | 20,000 | $5.49 | $109,800.00 |
DisclosureSEC source: 0001209191-17-033404 · doc4.xml · nonDerivative · entry 1 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:47 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001209191-17-004636 · doc4.xml · derivative · entry 6 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,610 Underlying: Common Stock · 15,000 shares Expires 2020-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock option vested as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:47 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 1,300 | $38.81 | $50,453.00 |
DisclosureSEC source: 0001209191-17-004636 · doc4.xml · nonDerivative · entry 3 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,870 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $38.90, inclusive. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:47 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 13,700 | $38.37 | $525,669.00 |
DisclosureSEC source: 0001209191-17-004636 · doc4.xml · nonDerivative · entry 2 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,170 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.75 to $38.70, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:47 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 15,000 | $5.49 | $82,350.00 |
DisclosureSEC source: 0001209191-17-004636 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · balance_after: Includes 233 shares of common stock acquired under the issuer's employee stock purchase plan in December 2016. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:50 UTC |
Scibetta James SPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,627 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001209191-17-004637 · doc4.xml · derivative · entry 6 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,251 Underlying: Common Stock · 17,627 shares Expires 2020-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:50 UTC |
Scibetta James SPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,373 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-17-004637 · doc4.xml · derivative · entry 5 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,373 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 50% of the options on September 2, 2010 and vests as to the remaining options in successive equal monthly installments for the subsequent 24 months. The options become exercisable, to the extent vested, from and after the issuer's initial public offering. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:50 UTC |
Scibetta James SPresident
|
SaleCommon Stock | 4,997 | $38.97 | $194,733.09 |
DisclosureSEC source: 0001209191-17-004637 · doc4.xml · nonDerivative · entry 4 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,084 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.05, inclusive. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:50 UTC |
Scibetta James SPresident
|
SaleCommon Stock | 15,003 | $38.39 | $575,965.17 |
DisclosureSEC source: 0001209191-17-004637 · doc4.xml · nonDerivative · entry 3 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,081 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.80 to $38.75, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:50 UTC |
Scibetta James SPresident
|
Exercise / conversionCommon Stock | 17,627 | $5.49 | $96,772.23 |
DisclosureSEC source: 0001209191-17-004637 · doc4.xml · nonDerivative · entry 2 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:50 UTC |
Scibetta James SPresident
|
Exercise / conversionCommon Stock | 2,373 | $1.61 | $3,820.53 |
DisclosureSEC source: 0001209191-17-004637 · doc4.xml · nonDerivative · entry 1 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| December 07, 2016 Filed Dec 10, 2016 01:22 UTC |
Braunstein ScottSVP, Strategy & Corp. Dev.
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-16-154554 · doc4.xml · derivative · entry 1 Braunstein Scott · CIK 0001643875 · SVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-12-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 20:27 UTC |
Weiland Robert J.Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-16-154560 · doc4.xml · derivative · entry 1 Weiland Robert J. · CIK 0001670648 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2026-12-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 20:23 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-16-154556 · doc4.xml · derivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2026-12-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| December 07, 2016 Filed Dec 10, 2016 01:27 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-16-154561 · doc4.xml · derivative · entry 1 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-12-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 20:26 UTC |
STACK DAVID MDirector · CEO and Chairman
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-16-154559 · doc4.xml · derivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2026-12-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 20:25 UTC |
Scibetta James SPresident
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-16-154558 · doc4.xml · derivative · entry 1 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-12-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| December 07, 2016 Filed Dec 10, 2016 01:24 UTC |
RIKER LAURENVice President, Finance
|
GrantStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-16-154557 · doc4.xml · derivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2026-12-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| December 07, 2016 Filed Dec 10, 2016 01:22 UTC |
Jones James BSVP & Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-16-154555 · doc4.xml · derivative · entry 1 Jones James B · CIK 0001650857 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-12-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 17:41 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001209191-16-150961 · doc4.xml · derivative · entry 6 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,610 Underlying: Common Stock · 15,000 shares Expires 2020-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vested as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 17:41 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 1,800 | $37.76 | $67,968.00 |
DisclosureSEC source: 0001209191-16-150961 · doc4.xml · nonDerivative · entry 3 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,637 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $37.85, inclusive. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 17:41 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 13,200 | $37.21 | $491,172.00 |
DisclosureSEC source: 0001209191-16-150961 · doc4.xml · nonDerivative · entry 2 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,437 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.675 to $37.65, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 17:41 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 15,000 | $5.49 | $82,350.00 |
DisclosureSEC source: 0001209191-16-150961 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 17:41 UTC |
Scibetta James SPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-16-150960 · doc4.xml · derivative · entry 3 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,373 Underlying: Common Stock · 20,000 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 50% of the options on September 2, 2010 and vests as to the remaining options in successive equal monthly installments for the subsequent 24 months. The options become exercisable, to the extent vested, from and after the issuer's initial public offering. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 17:41 UTC |
Scibetta James SPresident
|
SaleCommon Stock | 20,000 | $36.50 | $730,000.00 |
DisclosureSEC source: 0001209191-16-150960 · doc4.xml · nonDerivative · entry 2 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,084 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 17:41 UTC |
Scibetta James SPresident
|
Exercise / conversionCommon Stock | 20,000 | $1.61 | $32,200.00 |
DisclosureSEC source: 0001209191-16-150960 · doc4.xml · nonDerivative · entry 1 Scibetta James S · CIK 0001383242 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 17:47 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-16-145437 · doc4.xml · derivative · entry 4 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,695 Underlying: Common Stock · 30,000 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,377 option shares vested on February 3, 2011, and the remaining option shares vested in successive equal monthly installments for the subsequent 19 months. Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 17:47 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 30,000 | $1.61 | $48,300.00 |
DisclosureSEC source: 0001209191-16-145437 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.